FDA Investigator Richard Ledwidge (nmi), PhD

Richard Ledwidge (nmi), PhD has inspections in 14 countries as of 11 Oct 2023. Richard Ledwidge (nmi), PhD has collaborated with a combinined 5145 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
29
Last Inspection Date:
11 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, Korea (Republic of), Italy, Spain, Austria, Switzerland, Iceland, Taiwan, Ireland, Germany, Malaysia, France, Israel, China
Co-Investigator(s):
Adam R Cooke, Adetutu M Gidado, Alice S Tsao, Amy C Jordan, Amy Devlin, PhD, Amy N Chen, Anastasia G Lolas, Andrea Siegel, PhD, Andrew "Drew" Haack, PhD, Andrew Haack, PhD, Andrew J Barrowcliff, Andrew K Haack, PhD, Anh M Lac, Anita Narula, PhD, Anjali Shukla, PhD, Ann L Demarco, Ariel Cruz Figueroa, Arsen Karapetyan, Arulvathani P Arudchandran, Ashar P Parikh, Azza Talaat, Barbara Janine Breithaupt, Bo Chi, PhD, Brenda W Uratani, PhD, Brian A Roelofs, Brian Janelsins, PhD, Brooke K Higgins, Burnell M Henry, Calvin B Koerner, Candace Y Gomez Broughton, Carl A Huffman, III, Carolyn A Renshaw, CDR Donald Ertel, Chaltu N Wakijra, Charisse K Green, Charles Yuanchia Kuo, PhD, Chava Kimchi Sarfaty, PhD, Chen Sun, PhD, Chiang Syin, PhD, Christopher Downey, PhD, Christopher R Czajka, Concepcion Cruz, Jr, Cynthia Jim, CSO, Daniel J Lahar, Daniel J Roberts, Daniel Lahar, Daryl A Dewoskin, David M Beltran, Deborah M Trout, Debra J Bennett, Denise M Digiulio, Dennis Cantellops Paite, Devaughn Edwards, Diane Kelley, Diane L Raccasi, Dien N Nguyen, Dilip Devineni, PhD, Doan T Nguyen, PharmD, Dogbeda F Mackenzie, Donald C Obenhuber, PhD, Donna Ltartaglino Besone, Douglas A Campbell, Dr. Barbara D Paul, PhD, Dr. Ralph M Bernstein, PhD, Dr. Robert C Horan, MD, Edmund F Mrak, Jr, Eileen A Liu, Eliezar Ramos, Emily J Orban, Ephrem Hunde, PhD, Eric M Mueller, PharmD, Erika V Butler, Erin D Mccaffery, Felix Maldonado, Frances Namuswe, PhD, Francis A Guidry, Gerald B Seaborn, Jr, Guerlain Ulysse, Hamet M Toure, PharmD MPH, Hamet Toure, PharmD MPH, Haoheng Yan, PhD, Helen B Ricalde, Ian L Mcwilliams, Ivis Lnegron Torres, J Paul Kirwan, PhD, Jacek Cieslak, PhD, Jacqueline Mdiaz Albertini, James A Beaulieu, Javier E Santos, Jay T Wong, Jeanne Fringer, PhD, Jee Chung, PhD, Jeffrey M Watson, Jeffrey P Raimondi, Jennifer Swisher, PhD, Jens Fricke, Jessica Hankins, PhD, Jing Fang, Joan Johnson, Joey V Quitania, John D White, Jonathan W Chapman, Jose Acruz Gonzalez, Jose E Melendez, DDC, Joseph A Piechocki, Joseph R Strelnik, Joshua J Silvestri, Joslyn K Brunelle, PhD, Julie D Bringger, Junho Pak, Justin A Boyd, Kalavati Suvarna, PhD, Karen A Briggs, Katherine D Adams, Katherine Szestypalow, Kathleen R Jones, PhD, Kathryn E King, Kathy Lee, Kenneth G Klobus, Kevin A Gonzalez, Kristin M Abaonza, Kristy A Zielny, Kshitij A Patkar, Kurt A Brorson, PhD, Lakshmi Narasimhan, PhD, Lance M De Souza, MBA, Larry K Austin, Laura Fontan, MS, Laurie Graham, LCDR Chad N Thompson, Lei Zhang, PhD, Leiyun Boone, PhD, Leonard H Lavi, Linda F Murphy, Linda N Thai, Linda Thai, Lisa K Capron, Lori J Silverstein, LT Richard A Lyght, Lynda L Perry, PhD, Madushini Dharmasena, PhD, Marcus F Yambot, Margaret E Sarles, Maria Cecilia Tami, PhD, Maria Cruz Fisher, Maria G Gutierrez Hoffman, Maria Gutierrez Lugo, PhD, Maria I Cruz Fisher, Maria Joselopez Barragan, PhD, Mariza M Jafary, Mark Brunswick, PhD, Mark R Mcclain, Mary E Farbman, PhD, Mary E Storch, Maryam Tabatabaie, Massod Rahimi, PhD, Matthew B Casale, Maxwell Van Tassell, PhD, Megan A Haggerty, Melissa J Garcia, Michael A Charles, Michael E Maselli, Michael R Goga, Michael S Araneta, Michael Shanks, MS, Michele Perry Williams, Michelle Y Clark Stuart, Miguel A Martinez, Mihaly S Ligmond, Mikhail V Ovanesov, PhD, Milos Dokmanovic, PhD, Mindy M Chou, Monica Commerford, PhD, Mra Davism, Mra Mcculloughj, Mra Munizn, Nataniel Phillips Sylvain, PhD, Nealie C Newberger, Nebil A Oumer, Nibin Varghese, MS, Nicholas L Hunt, Omotunde O Osunsanmi, Patricia Fhughes Troost, Patrick C Klotzbuecher, Patty P Kaewussdangkul, Paul L Figarole, Jr, Paul Mouris, Peter Adams, PhD, Peter E Baker, Prabhu P Raju, Qing Joanna Zhou, PhD, Rabia Ballica, PhD, Rachel C Harrington, Rajiv R Srivastava, Ram Sihag, PhD, Raquel Gonzalez, Raquel Gonzalez Rivera, Rebecca Rodriguez, Reyes Candau Chacon, PhD, Richard K Vogel, Richard W Berning, Riley C Myers, PhD, Riley Meyers, Robert D Tollefsen, Robert J Ham, Robert J Martin, Robert W Jennings, Rochelle K Kimmel, Roger F Zabinski, Ronald G Crawford, Rong Guo, Rong Wang, PhD, Rose M Ashley, Russell J Glapion, S Lori Brown, PhD MPH, Sang Bong Lee, Santos E Camara, Sara H Gabel, Sarah Kennett, PhD, Scott R Nichols, PhD, Sean R Marcsisin, Shadia Zaman, PhD, Shawn E Larson, Shirley J Berryman, Sidney B Priesmeyer, Sony Mathews, Stacey S Degarmo, Steven D Kehoe, Steven E Bowen, PhD, Steven E Kane, Steven Fong, MS, PhD, Steven M Weinman, Stuart W Russell, Susan M Jackson, Susant Hadman, Tamil Arasu, PhD, Tara L Greene, Tara L King, Teegan Dellibovi Ragheb, PhD, Temar Q Williams, Thomas J Arista, Thuy T Nguyen, LCDR, Thuy Y Nguyen, Tracy Denison, PhD, Tricia S Martinez, Tzanko Stantchev, V Teres Speer, Vanessa Y Gelsey, PhD, Vanessa Y Jacobs, Veronica Fuentes, MS, Victor J Gangi, Vidya B Pai, Virgilio F Pacio, CSO, Viviana Matta, Walter N Lange, Warren J Lopicka, Wayne E Seifert, William Hallett, PhD, William V Millar, Willie Wilson, Xiaoshi Wang, Xu Michael Di, PhD, Yanming An, PhD, Yetao Jin, PhD, Yideng Liang, Yuan Chia Kuo, Yun Wu, PhD, Zerita White, Zhang Zhao, PhD, Zhihao Qiu (Peter), PhD, Zhong Li, PhD, Zhong Zhao, PhD, Ziyang Su, PhD

Richard Ledwidge (nmi), PhD's Documents

Publish Date Document Type Title
July, 2019 FDA 483 Bio-Technology General (Israel) Ltd. - Form 483, 2019-07-11
April, 2016 EIR Human Genome Sciences, Inc. - EIR, 2016-04-11
April, 2015 FDA 483 Regeneron Pharmaceuticals, Inc. - Form 483, 2015-04-03
November, 2020 EIR AGC Biologics, Inc. - EIR, 2020-11-02
January, 2023 FDA 483 Patheon Biologics LLC - Form 483, 2023-01-24
August, 2022 FDA 483 BIOCON SDN.BHD. - Form 483, 2022-08-30
November, 2018 EIR Boehringer Ingelheim RCV GmbH & Co KG - EIR, 2018-11-23
July, 2018 EIR CELLTRION Inc - EIR, 2018-07-17
May, 2022 FDA 483 Merck Biodevelopment - Form 483, 2022-05-24
April, 2017 FDA 483 Boehringer Ingelheim Fremont, Inc. - Form 483, 2017-04-04
November, 2020 FDA 483 Response AGC Biologics, Inc. - Form 483R, 2020-11-23
December, 2021 EIR Immunex Rhode Island Corporation - EIR, 2021-12-07
June, 2021 EIR Hanmi Pharm. Co., Ltd. - EIR, 2021-06-02
March, 2018 FDA 483 Eli Lilly Kinsale Limited - Form 483, 2018-03-16
February, 2009 EIR Bayer Healthcare Pharmaceuticals, Inc - EIR, 2009-02-05
December, 2021 FDA 483 Immunex Rhode Island Corporation - Form 483, 2021-12-07
November, 2018 FDA 483 Boehringer Ingelheim RCV GmbH & Co KG - Form 483, 2018-11-23
November, 2020 FDA 483 AGC Biologics, Inc. - Form 483, 2020-11-02
February, 2009 FDA 483 Bayer Healthcare Pharmaceuticals, Inc - Form 483, 2009-02-05
June, 2021 FDA 483 Hanmi Pharm. Co., Ltd. - Form 483, 2021-06-02
December, 2021 FDA 483 Response Immunex Rhode Island Corporation - Form 483R, 2021-12-20
July, 2018 FDA 483 CELLTRION Inc - Form 483, 2018-07-17
February, 2009 FDA 483 Response Bayer Healthcare Pharmaceuticals, Inc - Form 483R, 2009-02-27
March, 2023 FDA 483 Alvotech Hf - Form 483, 2023-03-17

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more